Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1346002

	registered interest
	date	13/07/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	When he plans to publish an updated Tobacco Control Plan.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	902649
	answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Government’s new Tobacco Control Plan will be published later this year.</p><p>It will set out a comprehensive package of ambitious policy proposals and supporting regulatory changes, to meet our ambition to be smoke free by 2030.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/07/2021 16:59:07 answering member 4380 label Biography information for Jo Churchill
	tabling member	4005 label Biography information for Bob Blackman

1281989

	registered interest
	date	29/01/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the recent example set by Singapore, what discussions his Department has had on when maritime key workers will be prioritised for covid-19 vaccinations.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	145777
	answer	answer is ministerial correction date of answer 16/02/2021 answer text <p>The Department has had a number of discussions on the prioritisation of key workers. The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who advise the Government on which vaccines the United Kingdom should use and provide advice on prioritisation at a population level. The JCVI’s advice has stated that phase one of the vaccine programme will have the prevention of mortality at the forefront of its objectives, as well as to support the National Health Service and social care system.</p><p> </p><p>Maritime staff who are eligible for a vaccine, based on the JCVI’s prioritisation, will be offered a vaccine in line with clinical advice. Prioritisation decisions for the next phase delivery of the vaccine are subject to information, surveillance and monitoring data from phase one, as well as further advice from independent scientific experts such as the JCVI. Phase two may include further reduction in hospitalisation and targeted vaccination of those at high risk of exposure and/or those delivering key public services.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 16/02/2021 10:02:16 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	4005 label Biography information for Bob Blackman

1461418

	registered interest
	date	10/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the letter from the Minister of State for Care and Mental Health to the Rt hon. Member for South West Surrey of 20 April 2022, what assessment he has made of the potential merits of bringing forward legislative proposals on early intervention and school and community-based measures for the mental health support of children and young people.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	199
	answer	answer is ministerial correction date of answer 17/05/2022 answer text <p>We have made no specific assessment. On 12 April 2022, we published a call for evidence to seek views on a range of issues from prevention to acute mental health care, which closes on 7 July 2022. This will support the development of a new 10-year cross-Government plan for mental health and wellbeing<em>.</em></p><p> </p><p>In addition, we have accelerated the deployment of mental health support teams to schools and colleges to support approximately 35% of pupils by 2023. We are working with the Department for Education to provide early intervention and mental wellbeing support in education settings.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 17/05/2022 09:25:20 answering member 4680 label Biography information for Gillian Keegan
	tabling member	4005 label Biography information for Bob Blackman

1352263

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the latest statistics published in NHS England’s Monthly Provider Based Data and Summaries, what assessment he has made of the effect of the covid-19 outbreak on the number of referrals for suspected prostate cancer; and if he will make a statement.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	41823
	answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>No formal assessment has been made.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 41825 question first answered 09/09/2021 10:28:48 answering member 4380 label Biography information for Jo Churchill
	tabling member	4005 label Biography information for Bob Blackman

1219155

	registered interest
	date	30/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of the 2017 Office for Health Economics report entitled Comparing Access to Orphan Medicinal Products in the United Kingdom and other European countries, what steps his Department is taking to help ensure that people with rare diseases can access the latest treatments.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	66850
	answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) issues guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources through its technology appraisal (TA) and highly specialised technologies (HST) programmes, including drugs for patients with rare diseases. 86% of NICE’s TA recommendations, and 100% of its HST recommendations, for orphan drugs have been positive since 2013.</p><p>Through the Early Access to Medicines Scheme, we are already making important drugs available to patients. So far around 1,500 patients have benefited from the scheme, which enables drugs to be used in clinical practice in parallel with later stages of the regulatory process.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 09:54:14 answering member 4380 label Biography information for Jo Churchill
	tabling member	4005 label Biography information for Bob Blackman

1663112

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 17 April 2023, HCWS710, on Achieving Smokefree 2030: cutting smoking and stopping kids vaping, whether his Department has conducted modelling on the potential impact of the measures outlined in the statement on progress towards the target of reducing smoking rates to 5% or less by 2030.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	200966
	answer	answer is ministerial correction date of answer 18/10/2023 answer text <p>Annex 1 of ‘Stopping the start: our new plan to create a smokefree generation’ sets out the modelling used to forecast changes in smoking prevalence over time based on legislating for a smokefree generation. This modelling is preliminary and will continue to be further refined ahead of publication of a full impact assessment.</p><p>Annex 1 is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/stopping-the-start-our-new-plan-to-create-a-smokefree-generation/annex-1-modelling-assumptions" target="_blank">https://www.gov.uk/government/publications/stopping-the-start-our-new-plan-to-create-a-smokefree-generation/annex-1-modelling-assumptions</a></p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 200880 200886 200929 200949 201232 201315 question first answered 18/10/2023 14:11:12 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4005 label Biography information for Bob Blackman

1467466

	registered interest
	date	01/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the US FDA's withdrawal of authorisation for the use of Sotrovimab for treatment of covid-19 on 5 April 2022, what steps he is taking to ensure the (a) stringency and (b) consistency of his Department's reviews of (i) Evusheld and (ii) other covid-19 treatments.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	11650
	answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The Antivirals and Therapeutics Taskforce engages with other nations to share learning on the use, deployment and evaluation of COVID-19 therapeutics and antivirals which may inform policy. The UK Health Security Agency is monitoring the effectiveness of all COVID-19 therapeutics, including sotrovimab. The RAPID C-19 collaborative, the National Health Service and other relevant experts provide advice to the United Kingdom Chief Medical Officers on whether treatments should be recommended for deployment, taking account of all available evidence.</p><p>The Department is currently reviewing prophylaxis and the efficacy of Evusheld. The Therapeutics Clinical Review Panel provides advice on the appropriate patient cohorts for potential new COVID-19 therapies, including preventative treatments. Final clinical policies and eligibility would be proposed by the NHS and agreed by the UK Chief Medical Officers.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 10:16:47 answering member 4447 label Biography information for Maggie Throup
	tabling member	4005 label Biography information for Bob Blackman

1218809

	registered interest
	date	29/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Rare Diseases: Patients
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the UK strategy for rare diseases: implementation plan for England published on 29 January 2018, what progress the Government has made on working with providers to produce alert cards for patients with rare diseases; and whether people with thrombotic thrombocytopenic purpura (TTP) will be included in the list of those eligible to receive an alert card.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	66030
	answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>In 2019, NHS England identified those specialised services in which patients with rare diseases are treated and asked the 150 providers that deliver these services to self-assess against three key criteria: care coordination; alert cards; and transition. In total, 1,000 clinical teams undertook the assessment and the completion rate was 85%. Of those providers that self-assessed: 91% confirmed that there is a person responsible for coordinating the care of any patient with a rare disease; 56% confirmed that they gave each person an alert card; and 91% confirmed that they had active transition in place.</p><p>Alert cards are already used in some hospitals that treat patients with thrombotic thrombocytopenic purpura. NHS England is currently in the process of commissioning a service for patients with thrombotic thrombocytopenic purpura. Once a full, national service is established, an alert card will be rolled out across the service.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 10:07:56 answering member 4380 label Biography information for Jo Churchill
	tabling member	4005 label Biography information for Bob Blackman

1354947

	registered interest
	date	13/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Rapid Cancer Registration and Treatment Data published by the National Disease Registration Service, what assessment he has made of the implications for his policies of the data in that publication that shows 13,000 fewer prostate cancer diagnoses to the end of April 2021 compared with historical trends; and what plans he has to increase the rate of those diagnoses.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	48193
	answer	answer is ministerial correction date of answer 21/09/2021 answer text <p>We are encouraging all those with cancer symptoms to come forward for treatment, though media engagement such as the ‘Help us to help you ‘campaign. There are currently eleven urology or prostate Rapid Diagnostic Centre (RDC) pathways operational or in development, some of which cover multiple hospital sites. RDCs have been developed to deliver faster and earlier cancer diagnosis, including for prostate cancer. RDCs will be the default model for all cancer pathways across all 21 Cancer Alliances in England by 2024.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 48192 question first answered 21/09/2021 16:47:18 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4005 label Biography information for Bob Blackman

1352264

	registered interest
	date	03/09/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the National Disease Registration Service’s Rapid Cancer Registration and Treatment Data, what recent assessment he has made of the trend in the level of prostate cancer diagnoses up to the end of April 2021; and what steps he is taking to improve the diagnosis of prostate cancer.
	tabling member constituency	Harrow East
	tabling member printed	Bob Blackman
	uin	41824
	answer	answer is ministerial correction date of answer 10/09/2021 answer text <p>The number of people coming forward with symptoms and being referred with suspected cancer recovered throughout 2020. Urological cancers, including prostate cancer, referrals were almost at pre-pandemic levels by June 2021.</p><p>The latest phase of the ‘Help us help you’ campaign raises awareness of abdominal symptoms of cancer, including for urological cancers. Awareness of prostate cancer risk and symptoms is also being raised through media and charities. Those presenting to their general practitioner with symptoms which could be prostate cancer will be assessed and referred in line with National Institute for Health and Care Excellence’s guidance, which states that they should be referred on a suspected cancer pathway for an appointment within two weeks. This guidance has remained in place throughout the pandemic.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/09/2021 13:20:14 answering member 4380 label Biography information for Jo Churchill
	tabling member	4005 label Biography information for Bob Blackman